MARKET WIRE NEWS
  1. Home
  2. Stock
  3. BBIO
  4. News
  5. Pgim Jennison Health Sciences Fund Q4 2025 Key Contr
BBIO
Quote
Short
News
Articles
Message Board

PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors

Source: SeekingAlpha

2026-03-15 23:25:00 ET

The following segment was excerpted from the PGIM Jennison Health Sciences Fund Q4 2025 Commentary. ...

Read the full article on Seeking Alpha

For further details see:

PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors
BridgeBio Pharma Inc.

NASDAQ: BBIO

BBIO Trading

-3.28% G/L:

$70.12 Last:

333,872 Volume:

$72.33 Open:

mwn-alerts Ad 300

BBIO Latest News

March 23, 2026 07:30:00 am
BridgeBio to Present Long-Term Efficacy and Safety Data from the ATTRibute-CM OLE Trial at the ACC Annual Scientific Sessions
March 11, 2026 02:00:00 pm
BBP-418 Demonstrates Consistent Efficacy and Favorable Safety Profile in Phase 3 FORTIFY Interim Analysis in LGMD2I/R9
March 10, 2026 05:15:05 pm
Overweight Recommendation Issued On BBIO By Barclays
March 04, 2026 07:30:00 am
BridgeBio to Present Additional Data from the Phase 3 FORTIFY Trial at the 2026 MDA Clinical & Scientific Conference

BBIO Stock Data

$13,905,867,946
157,635,809
2.34%
155
N/A
Biotechnology & Life Sciences
Healthcare
https://www.bridgebio.com
US
Palo Alto

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App